FINANCIALS

AVDL Avadel Pharmaceuticals Plc 1012477

Income Statement
Revenue	avdl-20240930	50,025,000
Net Income	avdl-20240930	-2,625,000
Profit Margin		-5.25%

Balance Sheet
Current Assets	127,258,000
Assets	158,253,000
Current Liabilities	42,783,000
Liabilities	83,590,000
Equity	74,663,000
Shares Out	96,271,000

Cash Flow Statement
Operating Cash Flow	-54,780,000
Investing Cash Flow	36,867,000

Market Analysis
Market Cap	1,319,868,695
Price	7.75
BVPS	0.78
PB	10.03
EPS	-1.17
PS	6.60
FCF	-17,913,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view AVDL documents filed with the SEC.

AVDL Filings Clear

View A List of Tickers